Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Thomas Hodge"'
Autor:
Hamad Ahmed, Prokopis Hadjisolomou, Kealan Naughton, Aaron Alejo, Stephanie Brauckmann, Giada Cantono, Simon Ferguson, Mirela Cerchez, Domenico Doria, James Green, Deborah Gwynne, Thomas Hodge, Deepak Kumar, Andrea Macchi, Rajendra Prasad, Oswald Willi, Marco Borghesi, Satyabrata Kar
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Developing compact ion accelerators using intense lasers is a very active area of research, motivated by a strong applicative potential in science, industry and healthcare. However, proposed applications in medical therapy, as well as in nuc
Externí odkaz:
https://doaj.org/article/d48c7171bd6448b7b54f7828115fffb4
Autor:
Paul E. Harris, Trevor Brasel, Christopher Massey, C. V. Herst, Scott Burkholz, Peter Lloyd, Tikoes Blankenberg, Thomas M. Bey, Richard Carback, Thomas Hodge, Serban Ciotlos, Lu Wang, Jason E. Comer, Reid M. Rubsamen
Publikováno v:
Vaccines, Vol 9, Iss 5, p 520 (2021)
Background: Persistent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has given rise to a COVID-19 pandemic. Several vaccines, conceived in 2020, that evoke protective spike antibody responses are being deployed in mass
Externí odkaz:
https://doaj.org/article/678fc80ad1ba43db995b78bda5058a94
Autor:
Todd G. Smith, Felix R. Jackson, Clint N. Morgan, William C. Carson, Brock E. Martin, Nadia Gallardo-Romero, James A. Ellison, Lauren Greenberg, Thomas Hodge, Luis Squiquera, Jamie Sulley, Victoria A. Olson, Christina L. Hutson
Publikováno v:
Viruses, Vol 12, Iss 2, p 177 (2020)
Currently, no rabies virus-specific antiviral drugs are available. Ranpirnase has strong antitumor and antiviral properties associated with its ribonuclease activity. TMR-001, a proprietary bulk drug substance solution of ranpirnase, was evaluated ag
Externí odkaz:
https://doaj.org/article/71fa94ae4d28456faa8722a4ab986a90
Publikováno v:
Code4Lib Journal, Iss 41 (2018)
At the American University of Sharjah, our Databases by title and by subject pages are the 3rd and 4th most visited pages on our website. When we changed our ILS from Millennium to OCLC’s WorldShare Management Services (WMS), our previous automatio
Externí odkaz:
https://doaj.org/article/27efa97fdbb140cc82545ad999dfb756
Dangerous convictions : what's really wrong with the U.S. Congress / Tom Allen. [elektronicky zdroj]
Autor:
Allen, Thomas H. (Thomas Hodge), 1945-, author
Externí odkaz:
Kolekce e-knih KNAV
Publikováno v:
Emerging Infectious Diseases, Vol 3, Iss 3, Pp 261-271 (1997)
Since the late 1970s, 8.4 million people worldwide, including 1.7 million children, have died of AIDS, and an estimated 22 million people are infected with human immunodeficiency virus (HIV) (1). During 1995 and 1996, major clinical and laboratory di
Externí odkaz:
https://doaj.org/article/9febaa3c89364af6a428b122da1a2a18
Autor:
Thomas Hodge, James RW MacDonald
Publikováno v:
Code4Lib Journal, Iss 21 (2013)
This article briefly examines the mechanisms behind seemingly counter-intuitive phrase search results in Serials Solutions’ discovery platform Summon. The authors use the platform’s search API to explain why users sometimes encounter greater numb
Externí odkaz:
https://doaj.org/article/1028ed45c50f4e9dbde5e6f563ff611b
Autor:
C. V. Herst, Richard Carback, William Chong Hang Chao, Peter M. Lloyd, Daniela Santoro Rosa, Alessandro Sette, Thomas Hodge, Reid M. Rubsamen, Edecio Cunha-Neto, Paul L. Harris, Shane Massey, Lu Wang, Scott Burkholz, Serban Ciotlos, John Sidney, Trevor Brasel
Publikováno v:
Vaccine
The 2013-2016 West Africa EBOV epidemic was the biggest EBOV outbreak to date. An analysis of virus-specific CD8+ T-cell immunity in 30 survivors showed that 26 of those individuals had a CD8+ response to at least one EBOV protein. The dominant respo
Autor:
Mirela Cerchez, Domenico Doria, K. Naughton, James Green, Hamad Ahmed, Deepak Kumar, Simon Ferguson, R. Prasad, G. Cantono, Aaron Alejo, D. Gwynne, Andrea Macchi, Oswald Willi, S. Brauckmann, Thomas Hodge, Satyabrata Kar, P. Hadjisolomou, Marco Borghesi
Publikováno v:
Ahmed, H, Hadjisolomou, P, Naughton, K, Alejo, A, Brauckmann, S, Cantono, G, Ferguson, S, Cerchez, M, Doria, D, Green, J, Gwynne, D, Hodge, T, Kumar, D, Macchi, A, Prasad, R, Willi, O, Borghesi, M & Kar, S 2021, ' High energy implementation of coil-target scheme for guided re-acceleration of laser-driven protons ', Scientific Reports, vol. 11, no. 1, 669 . https://doi.org/10.1038/s41598-020-77997-w
Scientific Reports
Scientific reports (Nature Publishing Group) 11 (2021): 699-1–699-7. doi:10.1038/s41598-020-77997-w
info:cnr-pdr/source/autori:Ahmed H.; Hadjisolomou P.; Naughton K.; Alejo A.; Brauckmann S.; Cantono G.; Ferguson S.; Cerchez M.; Doria D.; Green J.; Gwynne D.; Hodge T.; Kumar D.; Macchi A.; Prasad R.; Willi O.; Borghesi M.; Kar S./titolo:High energy implementation of coil-target scheme for guided re-acceleration of laser-driven protons/doi:10.1038%2Fs41598-020-77997-w/rivista:Scientific reports (Nature Publishing Group)/anno:2021/pagina_da:699-1/pagina_a:699-7/intervallo_pagine:699-1–699-7/volume:11
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific reports (Nature Publishing Group) 11 (2021): 699-1–699-7. doi:10.1038/s41598-020-77997-w
info:cnr-pdr/source/autori:Ahmed H.; Hadjisolomou P.; Naughton K.; Alejo A.; Brauckmann S.; Cantono G.; Ferguson S.; Cerchez M.; Doria D.; Green J.; Gwynne D.; Hodge T.; Kumar D.; Macchi A.; Prasad R.; Willi O.; Borghesi M.; Kar S./titolo:High energy implementation of coil-target scheme for guided re-acceleration of laser-driven protons/doi:10.1038%2Fs41598-020-77997-w/rivista:Scientific reports (Nature Publishing Group)/anno:2021/pagina_da:699-1/pagina_a:699-7/intervallo_pagine:699-1–699-7/volume:11
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Developing compact ion accelerators using intense lasers is a very active area of research, motivated by a strong applicative potential in science, industry and healthcare. However, proposed applications in medical therapy, as well as in nuclear and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5548ca8bbb43b3ea241ac215ebd1b5b0
https://pure.qub.ac.uk/en/publications/high-energy-implementation-of-coiltarget-scheme-for-guided-reacceleration-of-laserdriven-protons(412b298d-28ab-4f05-8106-09b324d98e4f).html
https://pure.qub.ac.uk/en/publications/high-energy-implementation-of-coiltarget-scheme-for-guided-reacceleration-of-laserdriven-protons(412b298d-28ab-4f05-8106-09b324d98e4f).html
Autor:
Scott Burkholz, Thomas Bey, Reid M. Rubsamen, Paul L. Harris, Christopher Massey, Thomas Hodge, C. V. Herst, Peter M. Lloyd, Richard Carback, Trevor Brasel, Tikoes Blankenberg, Jason E. Comer, Lu Wang, Serban Ciotlos
Publikováno v:
Vaccines, Vol 9, Iss 520, p 520 (2021)
Vaccines
Volume 9
Issue 5
Vaccines
Volume 9
Issue 5
BackgroundPersistent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has given rise to a COVID-19 pandemic. Several vaccines, evoking protective spike antibody responses, conceived in 2020, are being deployed in mass publ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c23478b02015f04143ae6e9fd21fae